Cargando…

A systematic study on the prevention and treatment of retinopathy of prematurity in China

BACKGROUND: To identify the prevention situation, the main factors influencing prevention effects and to develop control measures over retinopathy of prematurity in China. METHODS: Using stratified random sampling method, we randomly selected 23 provincial and ministerial hospitals (8 in Guangdong p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shuman, Liang, Zhijiang, Du, Qiyun, Li, Zhankui, Tan, Guangming, Nie, Chuan, Yang, Yang, Lv, Xuzai, Zhang, Chunyi, Luo, Xianqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813392/
https://www.ncbi.nlm.nih.gov/pubmed/29444655
http://dx.doi.org/10.1186/s12886-018-0708-3
_version_ 1783300186043318272
author Xu, Shuman
Liang, Zhijiang
Du, Qiyun
Li, Zhankui
Tan, Guangming
Nie, Chuan
Yang, Yang
Lv, Xuzai
Zhang, Chunyi
Luo, Xianqiong
author_facet Xu, Shuman
Liang, Zhijiang
Du, Qiyun
Li, Zhankui
Tan, Guangming
Nie, Chuan
Yang, Yang
Lv, Xuzai
Zhang, Chunyi
Luo, Xianqiong
author_sort Xu, Shuman
collection PubMed
description BACKGROUND: To identify the prevention situation, the main factors influencing prevention effects and to develop control measures over retinopathy of prematurity in China. METHODS: Using stratified random sampling method, we randomly selected 23 provincial and ministerial hospitals (8 in Guangdong province, 5 in Hunan province and 10 in Shaanxi province), 81 municipal hospitals (38 in Guangdong province, 19 in Hunan province and 24 in Shaanxi province), 180 district and county hospitals (76 in Guangdong province, 57 in Hunan province and 47 in Shaanxi province) in China. A total of 284 hospitals were enrolled in the study, with questionnaires distributed investigating the status and constrain factors of ROP presentation. Significant outcomes were analyzed thereafter by SPSS 19.0. RESULTS: The screening rate of ROP in medical institutions from eastern, central and western China were 84.6%, 35.0% and 56.7%, respectively. The screening rate of tertiary and secondary medical institutions were 84.6% and 25.7% in the eastern, 35.0% and 4.9% in the central, 56.7% and 5.9% in the western region. Screening was carried out better in the tertiary than that in the secondary and primary institutions. Treatment for ROP was available in 15.7% of all the tertiary hospitals surveyed. Lack of professionals, equipments and technologies were considered to be major restrain factors for screening. CONCLUSIONS: The ROP screening and treatment status have demonstrated significant regional diversity due to uneven distribution of medical resources in China. Developed areas had established intraregional cooperation models, whereas less-developed areas should consider set up a large-scale, three-level ROP prevention network. It is of paramount importance that education and training towards ophthalmologists should be vigorously strengthened. It is strongly recommended that implement ROP telemedicine and integrated ROP prevention and management platforms through the Internet should be established. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12886-018-0708-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5813392
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58133922018-02-16 A systematic study on the prevention and treatment of retinopathy of prematurity in China Xu, Shuman Liang, Zhijiang Du, Qiyun Li, Zhankui Tan, Guangming Nie, Chuan Yang, Yang Lv, Xuzai Zhang, Chunyi Luo, Xianqiong BMC Ophthalmol Research Article BACKGROUND: To identify the prevention situation, the main factors influencing prevention effects and to develop control measures over retinopathy of prematurity in China. METHODS: Using stratified random sampling method, we randomly selected 23 provincial and ministerial hospitals (8 in Guangdong province, 5 in Hunan province and 10 in Shaanxi province), 81 municipal hospitals (38 in Guangdong province, 19 in Hunan province and 24 in Shaanxi province), 180 district and county hospitals (76 in Guangdong province, 57 in Hunan province and 47 in Shaanxi province) in China. A total of 284 hospitals were enrolled in the study, with questionnaires distributed investigating the status and constrain factors of ROP presentation. Significant outcomes were analyzed thereafter by SPSS 19.0. RESULTS: The screening rate of ROP in medical institutions from eastern, central and western China were 84.6%, 35.0% and 56.7%, respectively. The screening rate of tertiary and secondary medical institutions were 84.6% and 25.7% in the eastern, 35.0% and 4.9% in the central, 56.7% and 5.9% in the western region. Screening was carried out better in the tertiary than that in the secondary and primary institutions. Treatment for ROP was available in 15.7% of all the tertiary hospitals surveyed. Lack of professionals, equipments and technologies were considered to be major restrain factors for screening. CONCLUSIONS: The ROP screening and treatment status have demonstrated significant regional diversity due to uneven distribution of medical resources in China. Developed areas had established intraregional cooperation models, whereas less-developed areas should consider set up a large-scale, three-level ROP prevention network. It is of paramount importance that education and training towards ophthalmologists should be vigorously strengthened. It is strongly recommended that implement ROP telemedicine and integrated ROP prevention and management platforms through the Internet should be established. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12886-018-0708-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-14 /pmc/articles/PMC5813392/ /pubmed/29444655 http://dx.doi.org/10.1186/s12886-018-0708-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Xu, Shuman
Liang, Zhijiang
Du, Qiyun
Li, Zhankui
Tan, Guangming
Nie, Chuan
Yang, Yang
Lv, Xuzai
Zhang, Chunyi
Luo, Xianqiong
A systematic study on the prevention and treatment of retinopathy of prematurity in China
title A systematic study on the prevention and treatment of retinopathy of prematurity in China
title_full A systematic study on the prevention and treatment of retinopathy of prematurity in China
title_fullStr A systematic study on the prevention and treatment of retinopathy of prematurity in China
title_full_unstemmed A systematic study on the prevention and treatment of retinopathy of prematurity in China
title_short A systematic study on the prevention and treatment of retinopathy of prematurity in China
title_sort systematic study on the prevention and treatment of retinopathy of prematurity in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813392/
https://www.ncbi.nlm.nih.gov/pubmed/29444655
http://dx.doi.org/10.1186/s12886-018-0708-3
work_keys_str_mv AT xushuman asystematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT liangzhijiang asystematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT duqiyun asystematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT lizhankui asystematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT tanguangming asystematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT niechuan asystematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT yangyang asystematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT lvxuzai asystematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT zhangchunyi asystematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT luoxianqiong asystematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT xushuman systematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT liangzhijiang systematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT duqiyun systematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT lizhankui systematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT tanguangming systematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT niechuan systematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT yangyang systematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT lvxuzai systematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT zhangchunyi systematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina
AT luoxianqiong systematicstudyonthepreventionandtreatmentofretinopathyofprematurityinchina